Activation of the Clotting System: Heparin-Coated versus Non Coated Systems for Extracorporeal Circulation
Open Access
- 1 December 1997
- journal article
- research article
- Published by SAGE Publications in The International Journal of Artificial Organs
- Vol. 20 (12) , 708-712
- https://doi.org/10.1177/039139889702001211
Abstract
The purpose of this experimental study was to compare heparin-coated versus non-coated systems for extracorporeal membrane oxygenation (ECMO), to investigate the dynamic course of clotting activation in both groups. Methods.: Eight pigs weighing 19.7 (± 1.3) kg, each underwent ECMO for 24 hours. Two groups were formed: in group 1, heparin-coated circuits were used with low dose heparinization (10 IU/kg/hr), whereas in group 2 non-coated circuits with high dose heparinization (60 IU/kg/hr) were used. Coagulation was monitored by measuring prothrombin time, partial thromboplastin time, fibrinogen, antithrombin III (AT III) and specific markers of clotting activation (thrombin-antithrombin III complexes (TAT) and D-dimer). Furthermore, platelet count, hematocrit, activated clotting time (ACT), and plasma heparin concentration were determined regularly. Results.: The dynamic course of the specific coagulation activation markers showed some differences: whereas TAT and D-dimer increased quickly in group 2, the increase in group 1 was delayed. Activation marker values tended to be lower in group 1 during the first six hours, after which no more differences between the groups were seen. After 24 hours of ECMO, TAT and D-dimer had nearly returned to baseline values. Platelets showed a continuous decrease throughout the experiment, which was very similar in both groups. Conclusions.: The heparin coated system showed a distinct delay in clotting activation during the first six hours of ECMO. After six hours there were no more differences between the groups.Keywords
This publication has 15 references indexed in Scilit:
- Activation of the clotting system during extracorporeal membrane oxygenation in term newborn infantsThe Journal of Pediatrics, 1996
- Effects on Coagulation and Fibrinolysis With Reduced Versus Full Systemic Heparinization and Heparin-Coated Cardiopulmonary BypassCirculation, 1995
- Safe use of heparin-coated bypass circuits incorporating a pump-oxygenatorThe Annals of Thoracic Surgery, 1994
- Complement activation during extracorporeal circulationThe Journal of Thoracic and Cardiovascular Surgery, 1993
- Heparin-coated circuits reduce activation of granulocytes during cardiopulmonary bypassThe Journal of Thoracic and Cardiovascular Surgery, 1992
- Twenty-four-hour heparin-free veno-right ventricular ECMO: An experimental studyThe Annals of Thoracic Surgery, 1992
- Platelet and neutrophil activation in cardiopulmonary bypassThe Annals of Thoracic Surgery, 1990
- Heparin Free Long-term Extracorporeal Circulation Using Bioactive SurfacesAnnual Northeast Bioengineering Conference, 1989
- Application of Surfaces with End Point Attached Heparin to Extracorporeal Circulation with Membrane LungsAsaio Journal, 1989
- A New Non-Thrombogenic Surface Prepared by Selective Covalent Binding of Heparin Via a Modified Reducing Terminal ResidueBiomaterials, Medical Devices, and Artificial Organs, 1983